BRIEF-Retrophin responds to U.S. Senate investigation on drug pricing
November 04, 2015 at 11:11 AM EST
* Retrophin responds to Senate investigation, spokesman says pharmaceutical pricing that strikes the right balance between affordability and innovation is of legitimate concern
